Sleep disturbances in parkinson disease and their potential role in heterogeneity

Journal of Geriatric Psychiatry and Neurology

Volumn 23, Issue 2, 2010, Pages 131-137

  Gunn, David G ^a   Naismith, Sharon L ^a   Lewis, Simon J G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cognitive impairment; Depression; Heterogeneity; Parkinson disease; Sleep disorders

Indexed keywords

CLINICAL FEATURE; COGNITION; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; INSOMNIA; MOOD DISORDER; NEUROPATHOLOGY; PARASOMNIA; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; REM SLEEP; REVIEW; SLEEP DISORDER; SLEEP PATTERN;

AGED; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM;

EID: 77951950672     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988709358591     Document Type: Review

References (76)

1. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones ; 1817.
2. Chaudhuri K., Healy D., Schapira A. Non-motor symptoms of Parkinsons disease: diagnosis and management. Lancet Neurol. 2006 ; 5 (3). 235-245. (Pubitemid 43238347)
3. Lees AJ, Blackburn NA, Campbell VL The nighttime problems of Parkinsons disease. Clin Neuropharmacol. 1988 ; 11 (6). 512-519.
4. Tandberg E., Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinsons disease. Mov Disord. 1998 ; 13 (6). 895-899. (Pubitemid 28517665)
5. Karlsen KH, Larsen JP, Tandberg E., M■land JG Influence of clinical and demographic variables on quality of life in patients with Parkinsons disease. J Neurol Neurosurg Psychiatry. 1999 ; 66 (4). 431-435. (Pubitemid 29145675)
6. Goetz CG, Stebbins GT Risk factors for nursing home placement in advanced Parkinsons disease. Neurology. 1993 ; 43 (11). 2227-2229. (Pubitemid 23346953)
7. Gjerstad MD, Aarsland A., Larson JP Development of daytime somnolence over time in Parkinsons Disease. Neurology. 2002 ; 58 (10). 1544-1546.
8. Marion MH, Qurashi M., Marshall G., Foster G. Is REM sleep Behaviour Disorder (RBD) a risk factor of dementia in idiopathic Parkinsons disease ? J Neurol. 2008 ; 255 (2). 192-196.
9. Fenelon G., Mahieux F., Huon R., Ziegler M. Hallucinations in Parkinsons disease: prevalence, phenomenology and risk factors. Brain. 2000 ; 123 (4). 733-745. (Pubitemid 30162723)
10. Happe S., Berger K. The association between caregiver burden and sleep disturbances in partners of patients with Parkinsons disease. Age Ageing. 2002 ; 31 (5). 349-354. (Pubitemid 35174522)
11. Stickgold R. Sleep-dependent memory consolidation. Nature. 2005 ; 437 (7063). 1272-1278. (Pubitemid 41568667)
12. Marshall L., Born J. The contribution of sleep to hippocampus-dependent memory consolidation. Trends Cogn Sci. 2007 ; 11 (10). 442-450. (Pubitemid 47588990)
13. Ferrara M., Iaria G., Tempesta D., et al. Sleep to find your way: the role of sleep in the consolidation of memory for navigation in humans. Hippocampus. 2008 ; 18 (8). 844-851.
14. Peigneux P., Laureys S., Fuchs S., et al. Are spatial memories strengthened in the human hippocampus during slow wave sleep ? Neuron. 2004 ; 44 (1). 535-545. (Pubitemid 39423353)
15. Marinelli L., Crupi D., Di Rocco A., et al. Learning and consolidation of visuo-motor adaptation in Parkinsons disease. Parkinsonism Relat Disord. 2009 ; 15 (1). 6-11.
16. Rauchs G., Bertran F., Guillery-Girard B., et al. Consolidation of strictly episodic memories mainly requires rapid eye movement sleep. Sleep. 2004 ; 27 (7). 395-401. (Pubitemid 44138798)
17. Kupfer DJ REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry. 1976 ; 11 (2). 159-174.
18. Kupfer DJ, Foster FG Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet. 1972 ; 2 (7779). 684-686.
19. Vogel GW, Vogel F., McAbee RS, Thurmond AJ Improvement of depression by REM sleep deprivation. Arch Gen Psychiatry. 1980 ; 37 (3). 247-253.
20. Manni R., Terzaghi M., Pacchetti C., Nappi G. Sleep disorders in Parkinsons disease: facts and new perspectives. Neurol Sci. 2007 ; 28 (Suppl 1). S1 - S5. (Pubitemid 46152123)
21. Beersma DGM, Van den Hoofdakker RH Can non-REM sleep be depressogenic? J Affect Disord. 1992 ; 24 (2). 101-108.
22. Takashima A., Petersson KM, Rutters F., et al. Declarative memory consolidation in humans: a prospective functional magnetic resonance imaging study. Proc Natl Acad Sci USA. 2006 ; 103 (3). 756-761. (Pubitemid 43153098)
23. Chee LYM, Chuah MWL Functional neuroimaging insights into how sleep and sleep deprivation affect memory and cognition. Curr Opin Neurol. 2008 ; 21 (4). 417-423.
24. Demet EM, Chicz-Demet A., Fallon JH, Sokolski KN Sleep deprivation therapy in depressive illness and Parkinsons disease. Prog Neuropsychopharmacol Biol Psychiatry. 1999 ; 23 (5). 753-784. (Pubitemid 29416753)
25. Ford DE, Kamerow DB Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? J Am Med Assoc. 1989 ; 262 (11). 1479-1484.
26. Spira AP, Friedman L., Aulakh JS, et al. Subclinical anxiety symptoms, sleep, and daytime dysfunction in older adults with primary insomnia. J Geriatr Psychiatry Neurol. 2008 ; 21 (1). 56-60. (Pubitemid 351257761)
27. Naismith SL, Norrie L., Lewis SJ, et al. Does sleep disturbance mediate neuropsychological functioning in older people with depression? J Affect Disord. 2009 ; 116 (1). 139-143.
28. Muangpaisan W., Intalapaporn S., Assantachai P. Neuropsychiatric symptoms in the community-based patients with mild cognitive impairment and the influence of demographic factors. Int J Geriatr Psychiatry. 2008 ; 23 (7). 699-703.
29. Borek LL, Kohn R., Friedman JH Mood and sleep in Parkinsons disease. J Clin Psychiatry. 2006 ; 67 (6). 958-963.
30. Riemann D., Berger M., Voderholzer U. Sleep and depression- results from psychobiological studies: an overview. Biol Psychol. 2001 ; 57 (1-3). 67-103. (Pubitemid 32651895)
31. Gagnon JF, Petit D., Latreille V., Montplaisir J. Neurobiology of sleep disturbances in neurodegenerative diseases. Curr Pharm Des. 2008 ; 14 (32). 3430-3445.
32. Jean-Louis G., von Gizycki H., Zizi F. Melatonin effects on sleep, mood and cognition in elderly with mild cognitive impairment. J Pineal Res. 1998 ; 25 (3). 177-183. (Pubitemid 28430598)
33. Lee ML, Swanson BE, de la Iglesia HO Circadian timing of REM sleep is coupled to an oscillator within the dorsomedial suprachiasmatic nucleus. Curr Biol. 2009 ; 19 (10). 848-852.
34. Arendt J., Rajaratnam SMW. Melatonin and its agonists: an update. Br J Psychiatry. 2008 ; 193 (4). 267-269.
35. Chaudhuri KR, Schapira AHV. Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009 ; 8 (5). 464-474.
36. Abbott GW, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005 ; 65 (9). 1442-1446. (Pubitemid 41552777)
37. Ondo WG, Dat Vuong K., Khan H., et al. Daytime sleepiness and other sleep disorders in Parkinsons Disease. Neurology. 2001 ; 57 (8). 1392-1936. (Pubitemid 32995718)
38. Mamikonyan E., Moberg P., Siderowf A., et al. Mild cognitive impairment is common in Parkinsons disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord. 2009 ; 15 (3). 226-231.
39. Wegelin J., McNamara P., Durso R., et al. Correlates of excessive daytime sleepiness in Parkinsons disease. Parkinsonism Relat Disord. 2005 ; 11 (7). 441-448. (Pubitemid 41526995)
40. Maquet P., Peters J., Aerts J., et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature. 1996 ; 383 (6596). 163-166. (Pubitemid 26303977)
41. Gjerstad MD, Boeve B., Wentzel-Larsen T., et al. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinsons disease over time. J Neurol Neurosurg Psychiatry. 2008 ; 79 (12). 387-391.
42. Postuma RB, Gagnon JF, Vendette M., et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009 ; 72 (15). 1296-1300.
43. Marion MH, Qurashi M., Marshall G., Foster G. Is REM sleep Behaviour Disorder (RBD) a risk factor of dementia in idiopathic Parkinsons disease ? J Neurol. 2008 ; 255 (2). 192-196.
44. Postuma RB, Lang AE, Massicotte-Marquez J., Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006 ; 66 (6). 845-851. (Pubitemid 43739758)
45. Gagnon J., Postuma RB, Mazza S., et al. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol. 2006 ; 5 (5). 424-432.
46. Boeve BF, Silber MH, Ferman TJ, et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord. 2001 ; 16: 622-630.
47. Fertl E., Auff E., Doppelbauer A., Waldhauser F. Circadian secretion pattern of melatonin in Parkinsons disease. J Neural Transm Park Dis Dement Sect. 1991 ; 3 (1). 41-47.
48. Bordet R., Devos D., Brique S., et al. Study of circadian melatonin secretion pattern at different stages of Parkinsons disease. Clin Neuropharmacol. 2003 ; 26 (2). 65-72. (Pubitemid 36397362)
49. Politis M., Piccini P., Pavase N., et al. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinsons disease: An in vivo 11C-raclopride PET study. Exp Neurol. 2008 ; 214: 112-116.
50. Ganjavi H., Shapiro C. Hypocretin/Orexin: a molecular link between sleep, energy regulation, and pleasure. J Neuropsychiatry Clin Neurosci. 2007 ; 19: 413-419. (Pubitemid 350156099)
51. Overeem S., van Hilten JJ, Ripley B., et al. Normal hypocretin-1 levels in Parkinsons disease patients with excessive daytime sleepiness. Neurology. 2002 ; 58 (3). 498-499. (Pubitemid 34150937)
52. Baumann C., Ferini-Strambi L., Waldvogel D., et al. Parkinsonism with excessive daytime sleepiness-a narcolepsy-like disorder ? J Neurol. 2005 ; 252 (2). 139-145. (Pubitemid 40385585)
53. Drouot X., Moutereau S., Nguyen JP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology. 2003 ; 61: 540-543. (Pubitemid 37025376)
54. Fronczek R., Overeem S., Lee SYY, et al. Hypocretin (orexin) loss in Parkinsons disease. Brain. 2007 ; 130 (6). 1577-1585. (Pubitemid 47355929)
55. Thannickal TC, Lai Y., Siegel JM Hypocretin (orexin) cell loss in Parkinsons disease. Brain. 2007 ; 130 (6). 1586-1595. (Pubitemid 47355933)
56. Thannickal TC, Moore RY, Nienhuis R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000 ; 27 (3). 469-474.
57. Diamond SG, Markham CH, Hoehn MM, et al. Effect of age at onset on progression and mortality in Parkinsons disease. Neurology. 1989 ; 39: 1187.
58. Hoehn MM, Yahr MD Parkinsonism: Onset, progression and mortality. Neurology. 1967 ; 17 (5). 427-442.
59. Jankovic J. Variable expression of Parkinsons disease. A baseline analysis of the DAT ATOP cohort. Neurology. 1990 ; 40 (10). 1529. (Pubitemid 20351344)
60. Woods SP, Troster AI Prodromal frontal/executive dysfunction predicts incident dementia in Parkinsons disease. J Int Neuropsychol Soc. 2003 ; 9 (1). 17-24.
61. Kumru H., Santamaria J., Tolosa E., Iranzo A. Relation between subtype of Parkinsons disease and REM sleep behavior disorder. Sleep Med. 2007 ; 8 (7-8). 779-783. (Pubitemid 47535012)
62. Postuma RB, Gagnon JF, Vendette M., et al. REM sleep behaviour disorder in Parkinsons disease is associated with specific motor features. J Neurol Neurosurg Psychiatry. 2008 ; 79 (10). 1117-1121.
63. Postuma RB, Gagnon JF, Vendette M., et al. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord. 2008 ; 23 (12). 1665-1672.
64. Sinforiani E., Zangaglia R., Manni R., et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinsons disease. Mov Disord. 2006 ; 21 (4). 462-466.
65. Aarsland D., Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinsons disease: a community-based study. Arch Neurol. 1999 ; 56 (5). 595-601. (Pubitemid 29218155)
66. Pacchetti C., Manni R., Zangaglia R., et al. Relationships between hallucinations, delusions, and rapid eye movement sleep behaviour disorder in Parkinsons disease. Mov Disord. 2005 ; 20 (11). 1439-1448. (Pubitemid 43072652)
67. Vendette M., Gagnon JF, Decary A., et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. 2007 ; 69 (19). 1843-1849. (Pubitemid 350071145)
68. Graham JM, Sagar HJ A data-driven approach to the study of heterogeneity in idiopathic Parkinsons disease: Identification of three distinct subtypes. Mov Disord. 1999 ; 14 (1). 10-20.
69. Lewis SJG, Foltynie T., Blackwell AD, et al. Heterogeneity of Parkinsons disease in the early stages using a data driven approach. J Neurol Neurosurg Psychiatry. 2005 ; 76 (3). 343-348.
70. Reijnders JS, Ehrt U., Lousberg R., et al. The association between motor subtypes and psychopathology in Parkinsons disease. Parkinsonism Relat Disord. 2008 ; 15 (5). 379-382.
71. Halliday G., Hely M., Reid W., Morris J. The progression of pathology in longitudinally followed patients with Parkinsons disease. Acta Neuropathol. 2008 ; 115 (4). 409-415.
72. Selikhova M., Williams DR, Kempster PA, et al. A clinicopathological study of subtypes in Parkinsons disease. Brain. (2009). 132 (11). 2947-2957.
73. Bronnick K., Aarsland D., Larsen JP Neuropsychiatric disturbances in Parkinsons disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand. 2005 ; 112 (3). 201-207. (Pubitemid 41176556)
74. Cummings JL, Mega M., Gray K., et al. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994 ; 44 (12). 2308.
75. Gagnon J., Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behaviour disorder. Neurology. 2006 ; 67 (5). 742-747. (Pubitemid 44394182)
76. Pahwa R., Stacy MA, Factor SA, et al. Ropinirole 24-hour prolonged release: Randomised, controlled study in advanced Parkinsons disease. Neurology. 2007 ; 68 (14). 1108-1115. (Pubitemid 46559844)